Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS CL A
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
17,967,898
-
Shares change
-
+17,955,400
-
Total reported value, excl. options
-
$175,188,000
-
Value change
-
+$175,066,000
-
Number of buys
-
24
-
Price
-
$9.75
Significant Holders of AFTERNEXT HEALTHTECH ACQUISI - SHS CL A (AFTR) as of Q4 2021
25 filings reported holding AFTR - AFTERNEXT HEALTHTECH ACQUISI - SHS CL A as of Q4 2021.
AFTERNEXT HEALTHTECH ACQUISI - SHS CL A (AFTR) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,967,898 shares
.
Largest 10 shareholders include GUGGENHEIM CAPITAL LLC (3,725,000 shares), CITADEL ADVISORS LLC (1,875,000 shares), UBS OCONNOR LLC (1,557,405 shares), FIR TREE CAPITAL MANAGEMENT LP (1,495,571 shares), MILLENNIUM MANAGEMENT LLC (1,290,998 shares), DEUTSCHE BANK AG\ (1,163,080 shares), Finepoint Capital LP (1,100,000 shares), MOORE CAPITAL MANAGEMENT, LP (1,000,000 shares), MARSHALL WACE, LLP (934,473 shares), and Sculptor Capital LP (639,993 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.